“The Union Budget 2026–27 reinforces the Government’s commitment to strengthening India’s healthcare ecosystem through sustained investments in infrastructure, domestic manufacturing and technology-led innovation. The continued focus on expanding access to diagnostics, critical care and advanced medical technologies is a positive step towards building a resilient and inclusive healthcare system.
For Indian medical technology manufacturers such as BPL Medical Technologies, the emphasis on indigenous production, research and development, and capability building across the healthcare value chain is encouraging. Support for manufacturing depth, skill development and improved access in Tier II, Tier III and underserved regions will be critical in advancing the Make in India vision and positioning India as a trusted global hub for high-quality medical technologies. We also look forward to continued momentum on earlier healthcare commitments, including the expansion of oncology infrastructure, which will be vital in addressing India’s growing cancer burden.”
— Dr Shravan, Managing Director, BPL Medical Technologies











.jpeg)